jCyte is a clinical-stage company focused on the application of progenitor cell-based technology in retinal diseases. The Company's allogeneic product candidate, jCell, is delivered by simple intravitreal injection without the need for surgery or immune suppression. 

Biotechnology

jCyte

jCyte's headquarters in Newport Beach, CA, United States

John Sholar

Angeline Lo

Joseph J. Ridolfi

Adrian Morris

Rob Beathard

Henry J. Klassen

Victor Chao

Jing Yang

Baruch D. Kuppermann

David S. Boyer

Jeffrey Heier

Peter K. Kaiser

The Scientific Advisory Team at jCyte plays a crucial role in guiding the company's research and development strategies. Comprised of experts in ophthalmology and regenerative medicine, the team provides insights on the scientific validity and innovative applications of jCell, ensuring the product aligns with the latest advancements in treating retinal diseases. Their expertise helps shape clinical trial designs, regulatory strategies, and overall scientific direction.

Scientific Advisory Team

This department manages and oversees clinical trials and regulatory submissions to ensure compliance and efficiency in clinical operations.

Clinical Operations

This department oversees financial management and strategic development initiatives.

Finance and Development

The Leadership Team at jCyte is responsible for setting the strategic direction and vision of the company, overseeing the development and implementation of innovative progenitor cell-based therapies for retinal diseases. They collaborate across scientific, operational, and corporate development functions to drive the advancement of jCell and ensure successful clinical outcomes while fostering partnerships and stakeholder engagement.

Leadership Team

The Scientific and Technical Roles team at jCyte is responsible for advancing the development and clinical application of jCell, leveraging expertise in research, medicine, and technology. This multidisciplinary team collaborates to oversee product development, ensure regulatory compliance, and optimize manufacturing processes, ultimately aiming to improve treatment outcomes for retinal diseases through innovative progenitor cell therapies.

jCyte

Org chart

Board & advisors

Teams

Scientific Advisory Team

Clinical Operations

Finance and Development

Leadership Team

Scientific and Technical Roles

Offices

jCyte

Org chart

Board & advisors

Teams

Scientific Advisory Team

Clinical Operations

Finance and Development

Leadership Team

Scientific and Technical Roles

Offices

Related companies